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OBJECTIVE: To investigate the overall estimates of cross-sectional areas (CSA) of the median 
nerve measured by ultrasonography in accordance with the electrodiagnostic classification of 
carpal tunnel syndrome (CTS) severity. 
DESIGN: MEDLINE (PubMed), EMBASE (Ovid), and Web of Science were searched for 
studies reporting the median nerve CSA measured by ultrasonography for mild, moderate and 
severe CTS based on electrodiagnostic study. CSA values measured at the carpal tunnel inlet 
were included in the analyses. 
RESULTS: Overall, 866 citations were retrieved and checked for eligibility. Finally, 16 articles 
were included for meta-analysis. These studies included a total sample of 2,292 wrists including 
776 mild, 823 moderate and 693 severe CTS. The pooled analysis revealed a mean CSA of 11.64 
mm
2
 (95% CI: 11.23-12.05 mm
2
; P< 0.001) for mild CTS; a mean CSA of 13.74 mm2 (95% CI: 
12.59-14.89 mm
2
; P< 0.001) for moderate CTS; and, a mean CSA of 16.80 mm2 (95% CI: 
14.50-19.1 mm
2
; P< 0.001) for severe CTS. 
CONCLUSION: This is the first meta-analysis that provides the pooled median nerve CSA 
values in accordance with the electrodiagnostic classification of CTS severity. The values 
obtained in this study have clinical utility in ultrasonographic assessment of patients with CTS. 
 
Keywords: Carpal Tunnel Syndrome; Ultrasonography; Electrodiagnosis; Diagnosis; Review; 
Meta-Analysis. 
  








Carpal tunnel syndrome (CTS) is the most common peripheral compression neuropathy of the 
median nerve in the upper limb. Depending on the criteria used for diagnosis, the prevalence has 
been reported to vary from 3% to 6% in the general population. There is a 3:1 female 
predominance with a mean age of onset in the early 40s. 
(1-3)
 The classic presentation is 
numbness and pain in the first three radial digits and the radial side of the forth finger 
corresponding to the innervation of the median nerve in the hand. The diagnosis is based 
primarily on clinical features, but electrodiagnostic studies are widely used to confirm the 
diagnosis and determine the stage of severity. 
(4, 5)
 
During the past decade, high-frequency ultrasonography is extensively being used in the field of 
neuro- musculoskeletal medicine. One major application is evaluation of peripheral nerve 
entrapments in the upper and lower limbs. The most reliable ultrasonographic indicator of 
peripheral nerve entrapment neuropathy is enlargement of the nerve cross-sectional area (CSA). 
(6)
 Many studies have compared the diagnostic yields of ultrasonography versus electrodiagnostic 
studies in patients with CTS. There is now mounting evidence that ultrasonography can be used 
as an alternative to electrodiagnostic studies in the diagnosis of CTS. 
(7, 8)
 A median nerve CSA 
≥10 mm
2
 at the level of the pisiform bone is the most consistent parameter for diagnosis of CTS 
by ultrasonography. The diagnostic sensitivity has been estimated to be as high as 97% using this 
parameter. 
(9, 10)
 Several studies have attempted to discover whether the CSA of the median nerve 
is useful for predicting the severity of median neuropathy as determined by nerve conduction 
studies or not. In recent years, increasing numbers of authors have provided data on the mean 
CSA of the median nerve in accordance with electrophysiological grading of CTS severity. 







However, the existing published data need to be consolidated into a full meta-analysis to 
determine the overall estimate of median nerve CSAs for mild, moderate and severe CTS. 
The purpose of this study was to conduct a meta-analysis on high-quality research to determine 
the overall estimates of median nerve CSA at carpal tunnel inlet for mild, moderate and severe 
CTS as defined by the electrodiagnostic studies. 
Materials and methods 
This systematic review was conducted in accordance with the Cochrane Collaboration guidelines 
(11)
 and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA 
statement (Supplemental Digital Content 1, http://links.lww.com/PHM/A709). 
(12)
 This study 
was exempt from ethical approval since it was a secondary analysis of a publicly available 
datasets. 
Sources and search strategy  
In December 2017, two authors (PR and SR) independently conducted a systematic search of 
MEDLINE (PubMed), EMBASE (Ovid), and Web of Science to identify relevant publications 
from the inception of the databases to 1 December 2017 without any restrictions. The following 
text words, Medical Subject Headings (MeSH) terms and Boolean operators were used: “carpal 
tunnel or carpal tunnel syndrome or median nerve”, “electrodiagnostic or electrophysiologic or 
electrodiagnostically or electromyography or nerve conduction or neurophysiologic”, and 
“ultrasound or ultrasonography or ultrasonographic, sonography or sonographic or 
sonographically”. The search was conducted without any language restriction. 
 
 







Inclusion and exclusion criteria 
The titles and abstracts of all collected studies were reviewed for relevance by the same authors 
(PR and SR). Disagreements were resolved through discussion to a third author (AB) when 
necessary. The criteria for study inclusion in this systematic review were as following: i) Study 
performing both high-frequency ultrasonography and electrodiagnostic study of the median 
nerve in patients with CTS; ii) Study reporting the median nerve CSA for mild, moderate and 
severe CTS in accordance with electrodiagnostic studies; iii) Clearly described electrodiagnostic 
grading scale for defining the severity of CTS, and, iv) Study published in full-text. We did not 
include case reports, case series, letters, review articles, technical reports and conference 
abstracts in this systematic review. The primary reason for not including some relevant articles 
was lack of describing a valid electrodiagnostic criteria for defining mild, moderate and severe 
CTS. The eligible studies that met the inclusion criteria were imported into EndNote® software 
version X7 (Thomson Reuters, Carlsbad, CA). 
Quality assessment 
We evaluated the scientific quality of the studies using the “STrengthening the Reporting of 
Observational Studies in Epidemiology” (STROBE) tool 
(13)
 (see Supplementary Checklist, 
Supplemental Digital Content 2, http://links.lww.com/PHM/A710). The STROBE is a standard 
international checklist for quality assessment of the observational studies including cohort 
studies, case-control studies, and cross-sectional studies. This tool evaluates components of the 
study design, methods for selecting participants, data collection, methods for measuring exposure 
and outcome variables, statistical methods, potential bias and methods to control for 
confounding. Studies with STROBE score <8 were not included in the meta-analysis. Two 







authors (PR and AA) performed the quality assessment separately and disagreements were 
resolved through discussion. 
Data extraction and outcome measures 
After enrollment of the eligible studies, one author (SR) extracted data from each article 
including the name of the first author, year of publication, number of patients, number of median 
nerves examined (number of wrists), mean age of the studied sample, gender ratio, and mean ± 
standard deviation (SD) of the median nerve CSA corresponding to mild, moderate and severe 
CTS. The extracted data were summarized into standard data tables designed for this review. For 
studies that reported various median nerve CSA measurements at different anatomical sites, we 
only included the median nerve CSAs measured at the level of pisiform bone (carpal tunnel inlet) 
in this analyses. 
As no generally accepted electrophysiological scale for grading the severity of CTS has been 
reached yet, studies included in the present review applied four different grading scales. These 
scales are derived from the publications by Steven 
(14)




 and Sucher. 
(17)
 
The details of these grading schemes are given in table 1. The Steven and Sucher scales use three 
grades as “mild”, “moderate” and “severe”, with a relatively similar electrophysiological criteria. 
The Padua and the Bland scales divide the mild and the severe grades into more subgroups, and 
use five and six grades, respectively. In order to conduct the met-analysis, we grouped the Bland 
and the Padua scales into three grades as following: 











Moderate CTS: Bland grade 3 (moderate); and Padua grade 3 (moderate). 
Severe CTS: Bland grade 4 (severe), grade 5 (very severe) and grade 6 (extremely severe); and 
Padua grade 4 (severe) and grade 5 (extreme). 
 
Data synthesis 
The pooled means of CSA in mild, moderate and severe CTS and their 95 % confidence intervals 
(CI) were evaluated using random-effects models. The pooled CSAs were synthesized by 
considering the means of each study weighted by its sample size (number of wrists) for mild, 
moderate and severe CTS. Chi-squared tests and I-squared statistics were used to evaluate the 
heterogeneity between the studies.  In the Chi-squared test, when the p value of Cochran's Q was 
lower than 0.1, the heterogeneity was considered. 
(18, 19)
 The results of I-squared test were 
interpreted as following: (i) 0-40 % might not be important, (ii) 30-60% might represent 
moderate heterogeneity, (iii) 50-90% might represent substantial heterogeneity, and (iv) 75-100 
% might indicate considerable heterogeneity. 
(11, 19)
 When heterogeneity between studies was 
detected, a leave-one-out sensitivity analysis was conducted by sequentially removing one study 
at a time and recalculating the results to assess the consistency of the results. To assess the 
publication bias, Funnel plots, Begg's test, and Egger's regression model were used. 
(20, 21)
 When 
publication bias was detected, trim and fill method was used to adjust the results. All statistical 
analysis were performed using Comprehensive Meta-Analysis Software version 3 (Biostat Inc., 
Englewood, New Jersey, USA). 
  








Eligibility of studies 
A total of 866 citations were identified by our initial search. Of these, 842 studies were excluded 
based on the title and abstract screening as they were irrelevant studies, duplicates, case reports, 
case series, letters, review articles, conference abstracts, and technical reports. Twenty four 
relevant studies were selected and their full texts were obtained for further assessments. On 
further scrutiny, eight studies were excluded from the meta-analysis primarily because of not 
describing a definite electrodiagnostic grading scale for defining mild, moderate and severe CTS. 
Finally, 16 studies with appropriate quality met the inclusion criteria for this meta-analysis. 
(22-37)
 
No additional citations were identified in searching the reference lists of the included studies. A 
summary of the searching strategy and selection process is illustrated in Figure 1. 
The included studies were all written in English language and were published from 2004 to 2017. 
They were all cross-sectional studies. These studies included a total sample of 2,292 wrists 
including 776 mild, 823 moderate and 693 severe CTS. Table 2 demonstrates the main 
characteristics of the 16 included studies. 
Quantitative Synthesis 
Heterogeneity was observed across the studies in means of CSA in all groups of mild, moderate 
and severe CTS. The details of heterogeneity analysis (I-square statistics) are described in table 
3. Accordingly, the random-effect models were used to pool the data.  The pooled analysis 
revealed a mean CSA of 11.64 mm
2
 (95% CI: 11.23-12.05 mm
2
; P< 00001) for mild CTS (figure 
2); a mean CSA of 13.74 mm
2
 (95% CI: 12.59-14.89 mm
2
; P< 00001) for moderate CTS (figure 







3); and, a mean CSA of 16.80 mm
2
 (95% CI: 14.50-19.1 mm
2
; P< 00001) for severe CTS (figure 
4). Among the included studies in the meta-analysis, 12 studies 
(22-29, 31, 33, 35, 36)
 reported the 
median nerve CSA for normal healthy volunteers/control subjects. The pooled analysis revealed 
a mean CSA of 8.21 mm
2
 (95% CI: 8.03-8.38 mm
2
; P< 0.001) for normal median nerves. 
Sensitivity analysis 
To evaluate the consistency of the results, a leave-one-out sensitivity analysis was performed by 
sequentially excluding one study at a time and recalculating the pooled means repeatedly. The 
sensitivity analysis revealed no significant change in the pooled means of CSA in all three 
severity grades of CTS when all studies were excluded one by one. This indicated the robustness 
and stability of the results. 
Publication bias analysis 
The results of Funnel plots, Begg's test, and Eggers tests revealed publication bias in the means 
of CSAs in moderate and severe CTS (table 4). To address the issue of publication bias, we 
performed trim and fill analysis to adjust the means of CSAs in moderate and severe CTS. The 
adjusted means for moderate and severe CTS were 13.43 mm
2









One of the main reasons for carrying out electrodiagnostic study in CTS is to assess the severity 
of the median neuropathy at the wrist. Many electrophysiological grading schemes exist for 
describing the severity of the CTS. These methods generally rely on measuring the degree of 
nerve conduction slowing across the carpal tunnel or determining whether or not sensory or 
motor action potentials are present. However, most available grading schemes are arbitrary in 









 The variety of grading schemes means there is no universally accepted 
electrophysiological scale for grading the severity of CTS. The most commonly used scales are 
derived from the publications by Steven 
(14)
, Padua et al 
(15)
 and Bland 
(16)
 (table 1). Steven’s used 
three grades as “mild”, “moderate”, and “severe”; but did not specify latency levels within each 
grade. Padua et al. suggested a five-grading scheme very similar to that of Steven’s scale, the 
difference being that it divides mild CTS into “minimal” and “mild” subdivisions, and severe 
CTS into “severe” and “extreme” subdivisions. They did not specify latency levels within each 
grade as well. Finally, Bland used six grades and determined specific latency cut-offs for each 
grade (table 1). These scales can be mapped onto each other to some extent, with Bland 
providing the greatest number of subdivisions, then Padua and then Stevens. In 2013, Sucher 
(17)
 
proposed a new grading scheme based on a combination of the ranking criteria used in prior 
publications by Bland, Stevens and Padua. This scheme uses three grades as mild, moderate and 
severe, and is suggested to be a non-arbitrary means of determining CTS severity. Although 
there are only slight variations between these grading scales, the controversy about classifying 
patients into mild, moderate, and severe CTS is probably the most important challenge for the 
research of CTS severity in general. However, in order to conduct the present meta-analysis, we 
grouped the Bland grades 1 and 2 (very mild, mild) and Padua grades 1 and 2 (minimal, mild) 
into “mild CTS”. Similarly, we grouped the Bland grades 4, 5 and 6 (severe, very severe, and 
extremely severe) and Padua grades 4 and 5 (severe, extreme) into “severe CTS”. 
 
In this systematic review and meta-analysis, we incorporated 16 studies assessing the median 
nerve CSA at the carpal tunnel inlet in accordance with the electrophysiological classifications of 
CTS severity. Based on findings of this study, the pooled results of the exiting literature for 







median nerve CSA was 11.64 mm
2
 for mild, 13.74 mm
2
 (adjusted: 13.43 mm
2
) for moderate, and 
16.80 mm
2
 (adjusted: 16.36 mm
2
) for severe CTS. To our knowledge, this is the first meta-
analysis that provides the pooled median nerve CSA values in accordance with the 
electrodiagnostic classification of CTS severity. The values obtained in this study have clinical 
utility in ultrasonographic assessment of patients with CTS. 
Increased nerve CSA is an important diagnostic finding in compression neuropathies. 
(6)
 
Prolonged compression of the nerve will result in changes in the neural microcirculation, and 
render the nerve susceptible to ischemia. Nerve ischemia is responsible for blood vessel 
endothelial permeability abnormalities, which can lead to intra-neural edema. With increased 
compression, there will be intrafascicular edema, fibrous tissue proliferation, and higher 
proportion of extracellular water contents in the affected nerve. These structural changes result in 
swelling of the nerve, which is reflected by increased nerve CSA in ultrasound examination. 
(6, 8, 
9)
 The associations between CTS severity and median nerve CSA have been demonstrated in 
several studies. In a study on 106 patients with moderate to severe CTS, Phongamwong et al. 
(36)
 
reported a significant positive correlation (r=0.56) between CTS severity and median nerve CSA 
measured at carpal tunnel inlet. Using receiver operator characteristics analysis, they showed that 
a cut-off value of 14 mm
2
 for median nerve CSA has 91.4% specificity and 42.3% sensitivity to 
rule in moderate to severe CTS. This cut-off value is very close to the pooled estimates of 13.74 
mm
2
 for moderate CTS obtained in our meta-analysis. Padua et al. 
(38)
 made a similar observation 
and reported a correlation coefficient of 0.80 between median nerve CSA and electrodiagnostic 
classification of CTS severity. In another study Karadağ et al. 
(24)
 evaluated the agreements 
between the two methods of electrodiagnostic studies and ultrasonography in classification of 
CTS severity. They showed a good agreement (Cohen's kappa coefficient = 0.619) between these 







two methods in classifying CTS as mild, moderate and severe. Despite these promising reports, a 
number of authors including Moran et al. 
(39)
 and Mhoon et al. 
(40)
 have found no significant 
correlation between the values of the median nerve CSA and electrodiagnostic severity scales. 
Ultrasonographic measurement of the median nerve CSA can be performed at the carpal tunnel 
inlet (the level of scaphoid-pisiform), or at the level of carpal tunnel outlet (the level of hamate-
trapezium). All studies included in this meta-analysis performed ultrasound measurements at the 
carpal tunnel inlet. Measurement of median nerve CSA at the carpal tunnel inlet is reportedly 
more sensitive for diagnosis of CTS. 
(9, 10)
 Additionally, it has been shown that measurement of 
the median nerve CSA at the carpal tunnel inlet has a better inter-reader reliability than the 
measurements at the carpal tunnel outlet. 
(39, 41)
 The poor inter-reader reliability at the carpal 
tunnel outlet may be explained by difficulty in visualizing the median nerve at this level, as the 
nerve moves more dorsally and is covered by a thick palmar skin. (
9, 37)
 However, it should be 
acknowledged that the ultrasonographic assessment of median nerve is highly dependent upon 
the skill and expertise of the practitioner. The way that the operator performs the ultrasound 
examination may greatly affect the values of measured CSAs. Considerable expertise are 
required to perform ultrasonographic assessment of the median nerve for diagnosis of CTS. 
 
Ultrasonography represents an emerging diagnostic technique to assess median neuropathy at 
wrist; it is an alternative to more traditional electrodiagnostic study. However, each technique 
has some advantages and some shortcomings. Ultrasonography provides real-time imaging of the 
carpal tunnel and allows dynamic evaluation of the median nerve and the surrounding structures. 
Imaging can be used for evaluating anatomic variations or possible compressing masses that may 
be responsible for median nerve compression. Furthermore, ultrasonography is non-invasive and 







requires a shorter examination time and lower costs than electrodiagnostic studies. 
(9)
 On the 
other hand, electrodiagnostic studies are more powerful in the assessment of differential 
diagnosis in individuals with symptoms that suggest CTS. For example, CTS often occurs in the 
context of a generalized peripheral polyneuropathy, for example in the setting of diabetes 
mellitus. Electrodiagnostic study is able to provide a more accurate assessment of the extent to 
which the symptoms may be due to a focal median mononeuropathy versus a generalized 
peripheral polyneuropathy in such a common situation. The same comment is also applicable for 
a C6-C7 radiculopathy that may appear clinically similar to CTS. At present time, the issue of 
which technique should be used as initial screening remains a matter of debate. As an example, 
Wong et al. 
(41)
 and Goldberg et al. 
(42)
 proposed diagnostic approaches that involved 
ultrasonography as the initial screening test for patients suspected with CTS, and secondary 
electrodiagnostic studies performed only when the ultrasonography results were negative. On the 
other hand, some authors 
(43)
 offered a counterproposal that clinicians should start the screening 
with nerve conduction study of the median nerve, instead of ultrasonography, because 
electrodiagnostic study is suggested to be more sensitive for diagnosis of median neuropathy at 
wrist. 
(44, 45)
 Despite these debates there is a broad consensus about the value of ultrasonography 
in providing complementary information regarding the nerve anatomy and the neighboring 
structures within the carpal tunnel. 
 
Study limitations 
In the present systematic-review, a rigorous literature search was carried out to consolidate the 
results of all relevant, high-quality studies. However, this study has a number of limitations. 
First, a number of relevant studies were not included in this meta-analysis mainly because their 







electrodiagnostic criteria for CTS classification was not well-described. The second limitation 
was lack of temperature control in a number of included studies. It is well-established that 
temperature can have a significant effects on neural conduction parameters. 
(46)
 Finally, 
considering the electrodiagnostic studies as the reference method for determination of CTS 
severity has a limitation as this test may be associated with some false-positive and false-
negative results. 
(47)
 The possibility of false positive and false negative results were neglected in 
almost all included studies. 
Conclusions 
In conclusion, the present meta-analysis synthesized the results of previous studies to provide the 
overall estimates of median nerve CSA in accordance with the electrodiagnostic classifications 
of CTS severity. The pooled results showed a median nerve CSA of 11.64 mm
2
 for mild, 13.74 
mm
2
 (adjusted: 13.43 mm
2
) for moderate, and 16.80 mm
2
 (adjusted: 16.36 mm
2
) for severe CTS. 
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Figure 1. Flow diagram for inclusion of the studies in the meta-analysis. 
Figure 2: The forest plot of mean cross-sectional areas for mild CTS. 
Figure 3: The forest plot of mean cross-sectional areas for moderate CTS. 
Figure 4: The forest plot of mean cross-sectional areas for severe CTS. 
  



















































Mild: Prolonged DSL or MNL ± SNAP amplitude below the lower limit of normal. 
Moderate: Abnormal median DSL as above, and prolonged median DML.  
Severe: Prolonged median DSL and DML with either an absent SNAP or mixed nerve action 
potentials, or low amplitude or absent thenar CMAP. Evidence of membrane instability, 




Minimal (grade 1): Abnormal segmental or comparative tests only. 
Mild (grade 2): Slowing of digit/wrist sensory nerve conduction velocity with normal DML. 
Moderate (grade 3): Slowing of digit/wrist sensory nerve conduction velocity with abnormal 
DML. 
Severe (grade 4): Absence of SNAP and abnormal DML. 




Very mild (grade 1): CTS demonstrable only with most sensitive tests. 
Mild (grade 2): Slow of digit/wrist sensory nerve conduction velocity with normal DML. 
Moderate (grade 3): SNAP amplitude preserved with DML < 6.5 ms. 
Severe (grade 4): SNAP amplitude absent but CMAP amplitude preserved, DML < 6.5 ms. 
Very severe (grade 5): DML > 6.5 ms with recordable CMAP amplitude. 




Mild: Prolonged DSL and/or median MNL, and; Normal or minimally prolonged DML, and; 







Amplitudes of all responses within normal range, and; No CB or mild CB, and; No thenar 
EMG abnormalities. 
Moderate: Prolonged DSL, MNL, and DML, and; Amplitudes of all tested responses may be 
diminished, typically a relative decrease, and; CB may be present, and; Minor thenar EMG 
abnormalities may be present. 
Severe: Unobtainable median SNAP (or low amplitude and very prolonged DSL), and; Low-
amplitude or unobtainable median mixed nerve response and, if present, very prolonged MNL, 
and; Low-amplitude or unobtainable median CMAP and, if present, very prolonged DML, 
and; CB may be present and pronounced, and; Thenar EMG abnormalities often present. 
Abbreviations: DSL: distal sensory latency; MNL: mixed nerve latency; SNAP: sensory nerve 
action potential; DML: distal motor latency CMAP: compound muscle action potential; EMG: 
electromyography; CB: conduction block. 
  









































































































































110 110 NA 
100:
10 









































































































































































































































Note: Data are presented as numbers or mean ± standard deviation. Abbreviations: F: females; 
M; males; CTS: carpal tunnel syndrome; CSA: cross-sectional are; NA: not available. 
                               
 
  







Table 3 Heterogeneity in studies. 
Parameters Q Df (Q) P value    
Mild CTS 212.76 15 0.000 92.95 
Moderate CTS 1329.161 15 0.000 98.87 
Severe CTS 2486.884 15 0.000 99.39 
 
  







Table 4. Bias in publications. 
Parameters Egger's test Begg's test 
t 95 % CI P value Z P value 
Mild CTS 0.22 -2.87 to 2.32 0.82 0.99 0.32 
Moderate 
CTS 
4.15 -13.93 to -4.44 0.00097 1.71 0.08 
Severe 2.95 -14.33 to -2.27 0.01 2.25 0.02 
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